1-3 of 3
Mrinal Dutia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retrospective Review of the Safety and Efficacy of High-Dose Methotrexate for Prevention of CNS Relapse in Diffuse Large B-Cell Lymphoma at Kaiser Permanente- Northern California (Jan 2015 - June 2019)

Lisa Y Law, Mrinal Dutia, Ryan Stevenson, Melanie Lau, Timothy Mok, Khoan Vu, Aye Min Soe, Alfredo R. Lopez, Sachdev Thomas, Hyma T. Vempaty, Aruna Gavini, Bijay Nair
Journal: Blood
Blood (2021) 138 (Supplement 1): 4583.
https://doi.org/10.1182/blood-2021-145144
Published: 2021
Journal Articles

Lenalidomide Overcomes FcγRIIIa-Mediated Resistance to Rituximab In Patients with Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (NHL): A Correlative Analysis of a Phase 2 Study

Mrinal Dutia, MD, Ian DeRoock, MD, Christine Reed-Pease, CCRP, Joseph Tuscano, MD
Journal: Blood
Blood (2010) 116 (21): 3967.
https://doi.org/10.1182/blood.V116.21.3967.3967
Published: 2010
Journal Articles

R 2 : Preliminary Results of a Phase II Study of Lenalidomide and Rituximab in Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (NHL).

Mrinal Dutia, MD, Ian DeRoock, MD, Karen Chee, MD, Robert O'donnell, MD, Christine Quirch, Christine Reed-Pease, Joseph Tuscano, MD
Journal: Blood
Blood (2009) 114 (22): 1679.
https://doi.org/10.1182/blood.V114.22.1679.1679
Published: 2009